Prof Leon AaronsBSc, MSc, PhD

Professor

Full contact details
View graph of relations

Publications

  1. Published

    Mefloquine pharmacokinetic-pharmacodynamic models: Implications for dosing and resistance

    Simpson, J. A., Watkins, E. R., Price, R. N., Aarons, L., Kyle, D. E. & White, N. J., 2000, In : Antimicrobial Agents and Chemotherapy. 44, 12, p. 3414-3424 10 p.

    Research output: Contribution to journalArticle

  2. Published

    Population pharmacokinetics of mefloquine in patients with acute falciparum malaria

    Simpson, J. A., Price, R., Ter Kuile, F., Teja-Isavatharm, P., Nosten, F., Chongsuphajaisiddhi, T., Looareesuwan, S., Aarons, L. & White, N. J., 1999, In : Clinical Pharmacology and Therapeutics. 66, 5, p. 472-484 12 p.

    Research output: Contribution to journalArticle

  3. Published

    How can we do pharmacokinetic studies in the tropics?

    Simpson, J. A., Aarons, L. & White, N. J., 2001, In : Transactions of the Royal Society of Tropical Medicine and Hygiene. 95, 4, p. 347-351 4 p.

    Research output: Contribution to journalArticle

  4. Published

    Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone

    Simpson, J. A., Hughes, D., Manyando, C., Bojang, K., Aarons, L., Winstanley, P., Edwards, G., Watkins, W. A. & Ward, S., Mar 2006, In : British Journal of Clinical Pharmacology. 61, 3, p. 289-300 11 p.

    Research output: Contribution to journalArticle

  5. Published

    Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection

    Simpson, J. A., Aarons, L., Collins, W. E., Jeffery, G. M. & White, N. J., 2002, In : Parasitology. 124, 3, p. 247-263 16 p.

    Research output: Contribution to journalArticle

  6. Published

    Mean residence time for drugs subject to enterohepatic cycling

    Shepard, T. A., Lockwood, G. F., Aarons, L. J. & Abrahams, I. D., Jun 1989, In : Journal of pharmacokinetics and biopharmaceutics. 17, 3, p. 327-345 18 p.

    Research output: Contribution to journalArticle

  7. Published

    Precision criteria to derive sample size when designing pediatric pharmacokinetic studies: Which measure of variability should be used?

    Salem, F., Ogungbenro, K., Vajjah, P., Johnson, T. N., Aarons, L. & Rostami-Hodjegan, A., 2014, In : Journal of Clinical Pharmacology. 54, 3, p. 311-317 6 p.

    Research output: Contribution to journalArticle

  8. Published

    Modelling and simulation in the development and use of anti-cancer agents: An underused tool?

    Rombout, F., Aarons, L., Karlsson, M., Man, A., Mentré, F., Nygren, P., Racine, A., Schaefer, H., Steimer, J. L., Troconiz, I. & Van Peer, A., Dec 2004, In : Journal of pharmacokinetics and pharmacodynamics. 31, 6, p. 419-440 21 p.

    Research output: Contribution to journalArticle

  9. Published

    Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer

    Ranson, M., Dean, E., Jodrell, D., Connolly, K., Danson, S., Jolivet, J., Durkin, J., Morris, S., Jowle, D., Ward, T., Cummings, J., Dickinson, G., Aarons, L., LaCasse, E., Robson, L. & Dive, C., 1 Apr 2009, In : Journal of Clinical Oncology. 27, 10, p. 1660-1666 6 p.

    Research output: Contribution to journalArticle

  10. Published

    Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years

    Pitsiu, M., Hussein, Z., Majid, O., Aarons, L., De Longueville, M. & Stockis, A., Apr 2004, In : British Journal of Clinical Pharmacology. 57, 4, p. 402-411 9 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...19 Next